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Abstract
The National Plan for the Elimination of Rubella was implemented in Spain in 2008 using
the logistics of the National Plan for the Elimination of Measles that have been employed
since year 2000. Molecular characterization of rubella virus (RUBV) is important for disease
surveillance and for monitoringelimination of the disease throughout the world.We describe
the first complete series of data regarding the circulation of RUBV genotypes in Spain. The
739-nucleotide fragment designated by theWHO for RUBV genotyping was sequenced in
88 selected cases collected from 1998 to 2014. Five genotypes were identified: 1E, 2B, 1J,
1I, and 1a. Genotype 1E was predominant between 1998 and 2003 but was replaced by
genotype 2B, which was detected in sporadic cases in 2004, 2006, 2008, 2012, 2013 and
2014. There was an outbreak of genotype 2B in Algeciras (Andalusia) in 2008. Genotype 1J
caused an outbreak in Madrid in 2004/2005 and sporadic cases in 2005 and 2007. Geno-
type 1I was found to have infected an immune-suppressed patient with neurological symp-
toms in 2008. Finally, vaccine strain RA 27/3 was detected in three sporadic cases, two of
them immune-suppressedand without a recent history of vaccination. This suggests that
during these years there were a series of importedsporadic cases and outbreaks, confirm-
ing the findings of epidemiological data analysis. The importationsources were generally
consistent with our geographic and cultural ties, mainly with Europe (genotypes 1E, 2B, 1I)
and Latin America (1J).
Introduction
Rubella virus (RUBV) usually causes a mild exanthematic disease, frequently accompanied by
adenopathy, and occasionally by arthralgia. Complications of this infection are rare and
include encephalopathy and thrombocytopenia.However, the most severe consequence of this
virus is the congenital rubella syndrome (CRS) when the infection occurs in pregnant women,
particularly during the first trimester of pregnancy [1].
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RUBV is a serologicallymonotypic virus. However, it displays enough genetic variability to
distinguish two clades, designated A and B, which include 12 recognized genotypes (1B, 1C,
1D, 1E, 1F, 1G, 1H, 1I, 1J, 2A, 2B, 2C) and a single provisional one (1a). This classification was
initially proposed in 2005 [2], and revised in 2007 [3] and 2013 [4], and relies on the sequenc-
ing of a fragment of 739 nucleotides (nt 8731–9469) from the gene coding for the envelope pro-
tein E1. This sequence encodes amino acids (aa) 159–404 (of 481) of the E1 protein. Although
our knowledge of the geographic distribution of rubella genotypes has grown substantially,
those present in many countries and regions remain unknown [5], even though rubella is still
recognized as a globally important disease in the general public health context [6]. This knowl-
edge is crucial for tracing the source of imported outbreaks in countries that are close to elimi-
nating rubella.Moreover, the pattern of circulation of RUBV genotypes is by itself an indicator
of the stage a territory has reached on the way to rubella elimination.
In Spain, monovalent rubella vaccine was introduced in the late 1970s, when it was adminis-
tered to 11-year-old girls in schools [7]. In 1981, one dose of the measles/mumps/rubella
(MMR) combined vaccine was introduced in the regular immunization schedule at the age of
15 months for all children. In 1996, a second dose at 11 years was introduced [8]. After 1999,
this second dose was given to four-year-old children [9]. At the national level in Spain, vaccine
coverage for rubella exceeds 95.3% for the first dose and 90.7% for the second dose [10]. As a
result of this vaccination program, the annual rate of incidence dropped by several orders of
magnitude, from hundreds in 1982 to fewer than one case per 100,000 habitants in the first
years of this century. Nevertheless, the pattern is very different in other regions of the world
and rubella infection remains endemic in many areas, or has been only recently targeted for
elimination, as is the case in Latin America [11]. The rubella vaccine was only introduced in
Latin American countries in the late 1990s, so many adult immigrants from those countries
who are resident in Spain are not immunized. These circumstances led to a small outbreak in
Madrid in 2003 [12], a larger one in 2004–2005 [13, 14, 15], and another one in Catalonia in
2005 [16] among Latin American immigrants and Spanish males born before the universaliza-
tion of the vaccine. The characterization of the genotype 1J strain causing the outbreak in
Madrid in 2005 [13] remains the only historical data of RUBV genotype circulation in Spain.
In this report, we describe the RUBV genotypes detected in Spain over a period of 17 years,
between 1998 and 2014, with the aim of establishing the pattern of virus circulation and testing
the hypothesis of the interruption of endemic circulation suggested by the incidence data. This
represents the first series of data obtained at national level.
Materials andMethods
Clinical samples
Eighty-eight clinical samples (nine of urine, eight of serum, three of blood, two of saliva, two of
cerebrospinal fluid [CSF], one isolate and 63 pharyngeal exudates) from 88 confirmed rubella
cases collected from 1998 to 2014 in several regions of Spain were studied (Tables 1 and 2).
Ethics statement
Specimens were collected at origin and processed in the National Center of Microbiology in
accordance withWHO recommendations [17]. All samples were anonymized.
The project was approved during its evaluation by the Technical Commission of Evaluation
of the Instituto de Salud Carlos III (ISCIII) and the National Agency of Evaluation and
Prospective.
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Viral isolation in cell culture
Isolation was performed as previously described [13, 18] in Vero and Vero E6 cells (from the
ISCIII collection).
RT and amplification
Total nucleic acids were extracted from samples and a fragment of 875 bp including the region
of E1 gene, recommended by theWHO for RUBV sequencing, was amplified as previously
described [13]. Sequences were aligned and analyzed together withWHO reference strains [3,
4] to determine the genotype. Finally, phylogenetic trees were obtained for each detected geno-
type including other RUBV sequences obtained from GenBank. Sequencemanagement and
phylogenetic constructions were carried out as previously described [13, 19].
Results
Genotype assignation of sequences obtained from samples
Five genotypes were detected (1E, 2B, 1J, 1I and 1a) in sporadic cases or outbreaks (Table 1;
Fig 1). Genotype 1E was detected in 1998 (Canary Islands) and in 2003 was associated with an
outbreak in Madrid [12]. It was the only genotype known to be circulating in Spain during this
period. It did not produce another sporadic case until 2009, in Malaga (Andalusia) (Table 1).
When analyzed with other 1E sequences available in GenBank (Fig 2), all the sequences were
found to be located at the base of the phylogenetic tree along with others from France, Italy,
United Kingdom, Belarus and Portugal from the same years. In particular, sample 216C98
from the Canary Islands was grouped with a sequence detected the same year in Portugal, and
sample 200928382 was grouped with sequences from the UK and Belarus. These results suggest
that all the imported strains of genotype 1E probably originated in Europe.
The GenBank accession numbers of RUBV sequences found in Spain, 1998/2014, are
shown in Table 2.
Only sporadic detections of genotype 2B in El Ejido (Almería, Andalusia) in 2004 and
Madrid in 2006 had been describeduntil the appearance of an outbreak in Algeciras (Cádiz,
Andalusia) in 2008, with associated cases arising in Madrid, Ceuta (a Spanish city located on
the coast of North Africa) and Valencia. Other sporadic cases were detected in Zaragoza,
Madrid and Valencia in 2012, Castile-LaMancha in 2013, and Granada (Andalusia) in 2014
(Table 1; Fig 2). All the Spanish sequences of genotype 2B, including those from the outbreak
in Algeciras (2008), represented by sequences 776F08 (17 equal sequences) and 951F08,
Table 1. RUBV Genotypes found in Spain, 1998/2014.
Region 1998 2003 2004 2005 2006 2007 2008 2009 2012 2013 2014
Andalusia 2B b 1J b 2B a 1E b 2B b
Aragón 2B b 1a b
Canary Islands 1E b
Castile-LaMancha 1I b 2B b
Catalonia 1J b
Ceuta 2B b
Madrid 1a b, 1E a 1J a 1J a 2B b 2B b 1a b 2B b
Valencia 2B b 2B b
aGenotypes in outbreaks.
bGenotypes in sporadic cases.
doi:10.1371/journal.pone.0162403.t001
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occupied a basal position in the phylogenetic tree with others found in GenBank collected from
several very different locations. Consequently, as it seems to be widespread around the world,
it is difficult to establish the geographical origin of the imports with certainty. Only sequence
69F04 showed any significant association with sequences detected the same year in France
(FN547017/Bordeaux.FRA/27.04SRC). Also, two sequences from Granada 2014 and Madrid
2012 grouped with an Indian sequence (JQ413980 RVI/Kannur-IND/09-09) with a significant
bootstrap value of 94 (Fig 3). Consequently, strains of genotype 2B that seemed to be circulat-
ing worldwide were frequently imported.
Table 2. GenBank accessionnumbers of RUBV sequences found in Spain, 1998/2014.
Sequences GenBank accessionnumbers Year City Genotype
0947570_1 KU601196 2009 Madrid 1a
1085F03 KU601203 2003 Madrid 1E
69F04 KU601197 2004 El Ejido (Almería) 2B
165F03 KU601198 2003 Madrid 1a
16815Zaragoza2012 (4) KU601215 2012 Alcañiz (Teruel) 2B
24433Madrid2012 KU601216 2012 Madrid 2B
2585Castile-LaMancha2013 KU601210 2013 Guadalajara 2B
11520Granada2014 (2) KU601213 2014 Granada 2B
16720Madrid2012 KU601214 2012 Madrid 2B
941536 KU601219 2009 Madrid 1a
1897F05 KU601208 2005 Seville 1J
941531 KU601218 2009 Madrid 1a
1329F08 KU601206 2008 Madrid 2B
0928382F KU601217 2009 Malaga 1E
1902F08 KU601209 2008 Alicante 2B
3819F06 KU601211 2006 Madrid 2B
921I08 KU601201 2008 Guadalajara 1I
1151I08A KU601205 2008 Guadalajara 1I
1151I08 KU601204 2008 Guadalajara 1I
1854F07 KU601207 2007 Barcelona 1J
216C98 KU601199 1998 La Laguna (Tenerife) 1E
5495F08 KU601212 2008 Madrid 2B
776F08 (17) KU601200 2008 Algeciras (Cádiz) 2B
1083F03 KU601202 2003 Madrid 1E
277E (30) EU518607 2005 Madrid 1J
577E EU518608 2005 Madrid 1J
581E EU518609 2005 Madrid 1J
701E EU518610 2005 Madrid 1J
719E EU518611 2005 Madrid 1J
825E EU518612 2005 Madrid 1J
837E EU518613 2005 Madrid 1J
856E EU518614 2005 Madrid 1J
888E EU518615 2005 Madrid 1J
896E EU518616 2005 Madrid 1J
1247E EU518606 2005 Madrid 1J
The numbers in parentheses represent the number of sequences.
doi:10.1371/journal.pone.0162403.t002
Rubella VirusGenotypes in Spain, 1998-2014
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A strain of genotype 1J caused a large outbreak in Madrid of about 460 cases in 2004–2005,
mainly affecting the Latin-American community [13, 14, 15], and a sporadic case was recorded
in Seville (Andalusia). The associated sequences seem to be related to three others detected in
Brazil in the same year (CQ329848/RioGrandedoSul.BRA/48.05) (Fig 4). One of them even
Fig 1. Phylogenetic relationships amongRUBV genotypes. The phylogenetic tree was obtained by Neighbor-
Joining analysis. (Black circle), reference strains; (Black square), strains detected during this study. The numbers in
parentheses represent the number of sequences.
doi:10.1371/journal.pone.0162403.g001
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showed a complete identity, suggesting importation from South America as the most probable
origin of the outbreak, given the origin of most of the affected population. Sequence 854F07,
detected two years later in Barcelona (Catalonia) was grouped in a different branch with two
sequences, one from Hong Kong (HM461998/Hong Kong.CHN/18.10) in 2010 and the other
from Canada (JN575762/BritishColumbia.can/25.11) in 2011, suggesting a different importa-
tion event from a different source.
A sporadic case produced by genotype 1I was detected in Guadalajara (Castile-LaMancha)
in 2008. The homology observed among the sequences associated with this case and reference
strains ranged between 96.2% and 97.4% for 1I, and from 88.9% (2A) to 96.4% (1B) across
other genotypes (data not shown). The sequences analyzed were grouped with 1I reference
sequences with a significant posterior probability of 0.97 in the Bayesian analysis (Fig 5). The
Fig 2. Phylogenetic relationships amonggenotype1E strains. The phylogenetic tree was obtained by Bayesian
inference. (Black circle), reference strains; (Black square), strains detected during this study.
doi:10.1371/journal.pone.0162403.g002
Rubella VirusGenotypes in Spain, 1998-2014
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patient was immunocompromised, since she had the underlying disease of recessive autosomal
polyclonal agammaglobulinemia. In March 2008 she was negative as shown by RT-PCR, for
measles, rubella and parvovirus B19 [18], and had high avidity-specific RUBV IgG, which
excluded a primary recent rubella infection.OnMay 14, RT-PCR gave positive results for
RUBV RNA from serum and cerebrospinal fluid (CSF) coincident with neurological symp-
toms. Two serum samples and a pharyngeal swab taken later on July were also positive for
RT-PCR. It proved possible to isolate RUBV from a cell culture of this last sample. The
sequences obtained from the various samples of this patient differed at as many as eight posi-
tions (Table 3). The possible source of infection is unknown because no sequences of this
Fig 3. Phylogenetic relationships amonggenotype2B strains.The phylogenetic tree was obtained by Neighbor-
Joining analysis. (Black circle), reference strains; (Black square), strains detected during this study.
doi:10.1371/journal.pone.0162403.g003
Rubella VirusGenotypes in Spain, 1998-2014
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genotype were available for that time in GenBank. The presence of genotype 1I is known in
Europe (Italy, Germany, and England) from the late 1980s and the beginning of the 1990s, and
it was detected for the last time in Italy in 1994. It has been considered inactive since then [10].
Finally, three cases were detected in Madrid in 2009 associated with strains with sequences
identical to the RA 27/3 vaccine strain used in Spain (Fig 6). A highlight was that two of these
three cases were immunocompromised individuals (no such information was available about
the third case). There is no evidence of recent vaccination against rubella in any of these cases.
Discussion
Genotyping is included in theWHO protocols for epidemiological surveillance of rubella as a
relevant indicator of the stage of elimination [2, 3, 4, 20] and a tool for tracing chains of trans-
mission, identifying sources of infection [13, 20] and confirming vaccine-associated cases [21].
This work reports the first complete series of data of RUBV genotype circulation in Spain, cov-
ering a 17-year period, and adding information to previous findings [13]. Due to the low inci-
dence of rubella during the years of the study the number of cases is not high.We were unable
to amplify viral RNA from a large collection of positive rubella IgM sera from the last 30 years,
stored at -20°C and frozen and thawed an unknown number of times for serological studies
(data not shown). During the early years (1998–2003) genotype 1E was most frequently
detected, probably having been imported from other European countries that also experienced
concomitant cases caused by this genotype [22, 23]. Genotype 2B subsequently replaced geno-
type 1E as the most frequently detected genotype. However, a large outbreak in 2005 was
caused by genotype 1J. These occurrences suggest a pattern of sporadic imports without estab-
lishment of endemic circulation by any genotype (Table 1; Fig 1). The pattern is consistent
with the extremely low incidence of rubella detected during these years and the many periods
free of cases longer than the incubation time of the disease [24]. All this suggests a lack of
Fig 4. Phylogenetic relationships amonggenotype1J strains.The phylogenetic tree was obtained by
Neighbor-Joining analysis. (Black circle), reference strains; (Black square), strains detected during this study.
doi:10.1371/journal.pone.0162403.g004
Rubella VirusGenotypes in Spain, 1998-2014
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indigenous circulation and a situation approaching the goal of elimination. However, as the
existence of local clusters of susceptible adults cannot be discounted, imported cases and even
self-limiting outbreaks could consequently occur as long as endemic circulation continues
somewhere in the world. The origins of imported rubella cases seem to have been different. For
the most frequently detected 1E and 2B genotypes, Europe seems to be the most frequent ori-
gin, although it is usually difficult to establish. The genotype 1J outbreak, which occurred in
Madrid in 2004–2005 [13, 14, 15], highlights the importance of generating sequence data about
rubella genotypes for epidemiological purposes. It affected about 460 patients, predominantly
Table 3. Differences in nucleotide and amino acid sequences obtaineddirectly from pharyngeal exudates and spinal fluid or isolated from pharyn-
geal exudate of a patient with genotype1I. Position refers to the sequenced fragment.
Sequences Dates Clinical samples Nucleotide Position
37 55 190 244 247 430 487 523 562 721
921I08 05/22/2008 CSF T C A C C C T G T G
1151I08 07/3/2008 Phar Ex C T A T T T C G C A
1151I08 07/15/2008 Isolate C T G T T T C C C A
doi:10.1371/journal.pone.0162403.t003
Fig 5. Phylogenetic relationships amonggenotype1I strains.The phylogenetic treewas obtained by
Bayesian inference. (Black circle), reference strains; (Black square), strains detected during this study.
doi:10.1371/journal.pone.0162403.g005
Rubella VirusGenotypes in Spain, 1998-2014
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Latin American immigrants, and adult Spanish males born in the early 1980s (around the time
the MMR vaccine was introduced [15]), who had not been immunized in previous campaigns
that had focused solely on 11-year-old girls [13, 14, 15]. In the original description of the
Madrid outbreak [1, 22] there was no evidence of the presence of genotype 1J in either Europe
or South America, and the origin of the outbreak could not be traced. After these papers were
published, several Brazilian 1J sequences from the same year, some of them identical to those
detected in the Madrid outbreak, were published. These new data indicated that the most prob-
able source of this outbreak was South America, the original provenance of most of the
patients. Although there was no evidence of recent travel to South America for any of the cases
detected earlier, an index case with a recent travel history could have beenmissed, since mild
or subclinical rubella is frequent [21, 25]. This highlights the importance of molecular epidemi-
ology on tracing the origin of rubella outbreaks and the necessity of generating enough
sequencing information available in databases such as RubeNs. Another 1J strain detected two
years later in a sporadic case from Catalonia is more similar to strains 1J of Asian origin, but
different from those responsible for the outbreak in Madrid.
The last rubella outbreak included in this study occurred in Algeciras (Cádiz) in 2008 and
was produced by genotype 2B. The origin is unknown and difficult to establish on the basis of
sequencing data, since there is evidence of circulation of this genotype in many parts of the
world at the same time. Phylogenetic trees show the strains of this outbreak in a branch includ-
ing sequences from very different origins as China, Vietnam, Japan, Argentina, Brazil, USA,
Bosnia-Herzegovina, England and France. The origin of the outbreak was attributed to a cruise
connecting the Spanish city of Algeciras with Morocco, although there was no information
available about rubella genotypes in Morocco at that time. It is of particular note that these
clinical rubella cases were initially missed because they were detected in the context of a con-
comitant measles outbreak. They could be discriminated only on the basis of laboratory diag-
nosis [26]. This illustrates the importance of the laboratory in the epidemiological surveillance
of vaccine-preventable viral rashes and, in particular, the necessity either of double measles/
rubella testing of initially negative cases or the use of multiplex genomic amplification tech-
niques, as was the case in this event.
The most surprising finding about the presence of rubella genotypes in Spain described in
this study is the case caused by genotype 1I, since this was considered to be inactive throughout
the world [20]. This genotype circulated in Europe (Germany, England, and Italy) between
1986 and 1994, but has not been reported since then [1, 6]. The virus was isolated in a 24-year-
Fig 6. Phylogenetic relationships amonggenotype1a strains.The phylogenetic tree was obtained by
Neighbor-Joining analysis. (Black circle), reference strains; (Black square), strains detected during this study.
doi:10.1371/journal.pone.0162403.g006
Rubella VirusGenotypes in Spain, 1998-2014
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old immune-compromised patient. The sequences were obtained from different locations as
CSF, serum and throat swab (Fig 5) and showed as many as eight differences among them
(Table 3). This is almost the same number of variations as were generated over a year during
the outbreak of genotype 1J in Madrid, which affected hundreds of people. It suggests the exis-
tence of a heterogeneous population within the patient that should have taken a long time to be
generated in the course of a persistent infection established at any time in the past. The age of
the patient is compatible with a primary infection during the time when the virus was circulat-
ing in other European countries such as Italy, France and Germany. The persistence of the
infection in the patient could be explained by their immune status. During this study the
RA27/3 vaccine strain was detected in four cases, none of which had a recent history of vacci-
nation. The sequence is the same as that obtained from vaccinemarketed in Spain. In a previ-
ous study, RUBV could be detected in three of 26 throat swab samples from children taken 10
to 14 days after vaccination. One of them was even recovered in culture [27]. This study
showed evidence of asymptomatic excretion of RA 27/3 vaccine strain after vaccination, while
the four cases analyzed in our study also suggest the possibility of secondary transmission.
Moreover, it is noteworthy that two of these patients were immunosuppressed and the virus
could be detected in as many as eight samples of one of them (data not shown). Unlike the case
described above, which was caused by genotype 1I, the sequences showed only a single varia-
tion, which is compatible with a recent infection.
In conclusion, we detected five different genotypes of RUBV (1E, 2B, 1J, 1I and 1a) in Spain
between 1998 and 2014, although there was no evidence of the continuous circulation of any of
them. This is consistent with an advanced stage on the way towards rubella elimination in
Spain, as suggested by the extremely low incidence. Europe and Latin America seem to be the
most common sources of importation of rubella in Spain, in accordance with the very close
geographical, social and cultural ties with the country. The discovery that a genotype consid-
ered extinct until then had caused persistent infection called into question the role of the
immune-compromised as a source of RUBV after elimination had been achieved. Finally, the
possibility of secondary transmission of vaccine virus among immune-compromised patients
also requires further study. Further global efforts to genotype RUBV are necessary to obtain a
more accurate picture of the global distribution of RUBV genotypes and the molecular epide-
miology of RUBV. It would also allow a better management of outbreaks and a more accurate
evaluation of worldwide progress towards the elimination of rubella.
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